Level playing field for Clostridium difficile diagnosis

The largest study of its kind has shown the most effective test for the diagnosis of Clostridium difficile (C-Diff), a bacterial infection which causes 15,000-20,000 deaths a year in hospitals in the United States.

C-Diff affects the digestive system, and is most common in treated with antibiotics for other infections.

The multi-centre study, carried out by UK researchers at the University of Leeds, in partnership with colleagues from the University of Oxford, University College London and St George's, University of London, tested more than 12,000 faecal samples from hospital patients to establish the best method for diagnosing C-Diff.

The findings have been published online in the journal Lancet Infectious Diseases today.

The study compared the main different ways of diagnosing C-Diff, including the two 'gold-standard' methods: a cytotoxin assay, which looks for the presence of C-Diff toxin in faecal samples; and cytotoxigenic culture, which looks to see if there are bugs present in faecal samples that could possibly produce C-Diff toxin.

The research team found that patients with faecal samples positive by the cytotoxin assay were almost twice as likely to die within 30 days as those patients with samples only positive by the alternative 'gold-standard' method (16.6% versus 9.7%). The findings mean that tests which detect the presence of toxin in faecal samples (the cytotoxin assay) are the most reliable indicators of true C-Diff.

Professor Mark Wilcox, of the University of Leeds and Leeds Teaching Hospitals NHS Trust, who is also the C-Diff lead for Public Health England, the nation's public health body, said:

"The diagnosis of C-Diff has become a complicated area with lots of alternative tests, and there has been considerable uncertainty about which are the best tests to use.

"This is a landmark study not only because of its size, but also because we followed what happened to patients. This meant we have been able to show confidently which are the best tests to use to diagnose C-diff.

"C-diff cases in the NHS have decreased markedly in number since their peak in 2007-08 but reliably diagnosing C-diff is a crucial way forward to continuing to fight this infection."

These findings highlight the importance of using appropriate tests to diagnose C-Diff, especially as it is not possible to diagnose the infection using laboratory tests. Treating for C-diff and preventing the spread of infections in hospitals rely on accurately identifying who has the infection, but also who may be capable of transmitting the bug. The study identified a way of using a combination of tests to identify who has C-diff and who could be at risk of spreading the bug to others.

add to favorites email to friend print save as pdf

Related Stories

The four-point test to predict death risk from C. difficile

Aug 01, 2013

A Clostridium difficile (C. diff) infection is one that can affect the digestive system and most commonly affects people staying in hospital. It is not generally a problem for healthy people but may infect those on antibiotic ...

Biologist fights deadly gut bacteria, C. diff

Aug 29, 2013

A Texas A&M University biologist has received a federal grant to study the fecal samples of hundreds of people to better understand the gut bacteria Clostridium difficile—the cause of some 14,000 deaths a year in Americ ...

Recommended for you

Travel restrictions could worsen Ebola crisis: experts

5 minutes ago

Travel restrictions could worsen West Africa's Ebola epidemic, limiting medical and food supplies and keeping out much-needed doctors, virologists said Tuesday as the disease continued its deadly spread.

World 'losing the battle' to contain Ebola: MSF

45 minutes ago

International medical agency Medecins sans Frontieres said Tuesday the world was "losing the battle" to contain Ebola and called for a global biological disaster response to get aid and personnel to west Africa.

Mutating Ebola viruses not as scary as evolving ones

1 hour ago

My social media accounts today are cluttered with stories about "mutating" Ebola viruses. The usually excellent ScienceAlert, for example, rather breathlessly informs us "The Ebola virus is mutating faster in humans than in animal hosts ...

War between bacteria and phages benefits humans

1 hour ago

In the battle between our immune systems and cholera bacteria, humans may have an unknown ally in bacteria-killing viruses known as phages. In a new study, researchers from Tufts University, Massachusetts ...

Ebola kills 31 people in DR Congo: WHO

3 hours ago

An outbreak of the Ebola virus in the Democratic Republic of Congo has killed 31 people and the epidemic remains contained in a remote northwestern region, UN the World Health Organization (WHO) said Tuesday.

User comments